219 related articles for article (PubMed ID: 21406632)
1. Tumor angiogenesis change estimated by using diffuse optical spectroscopic tomography: demonstrated correlation in women undergoing neoadjuvant chemotherapy for invasive breast cancer?
Pakalniskis MG; Wells WA; Schwab MC; Froehlich HM; Jiang S; Li Z; Tosteson TD; Poplack SP; Kaufman PA; Pogue BW; Paulsen KD
Radiology; 2011 May; 259(2):365-74. PubMed ID: 21406632
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes.
Jiang S; Pogue BW; Carpenter CM; Poplack SP; Wells WA; Kogel CA; Forero JA; Muffly LS; Schwartz GN; Paulsen KD; Kaufman PA
Radiology; 2009 Aug; 252(2):551-60. PubMed ID: 19508985
[TBL] [Abstract][Full Text] [Related]
3. Predicting breast cancer response to neoadjuvant chemotherapy using pretreatment diffuse optical spectroscopic texture analysis.
Tran WT; Gangeh MJ; Sannachi L; Chin L; Watkins E; Bruni SG; Rastegar RF; Curpen B; Trudeau M; Gandhi S; Yaffe M; Slodkowska E; Childs C; Sadeghi-Naini A; Czarnota GJ
Br J Cancer; 2017 May; 116(10):1329-1339. PubMed ID: 28419079
[TBL] [Abstract][Full Text] [Related]
4. Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy.
Li SP; Taylor NJ; Makris A; Ah-See ML; Beresford MJ; Stirling JJ; d'Arcy JA; Collins DJ; Padhani AR
Radiology; 2010 Dec; 257(3):643-52. PubMed ID: 20858850
[TBL] [Abstract][Full Text] [Related]
5. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography.
Zhu Q; DeFusco PA; Ricci A; Cronin EB; Hegde PU; Kane M; Tavakoli B; Xu Y; Hart J; Tannenbaum SH
Radiology; 2013 Feb; 266(2):433-42. PubMed ID: 23264349
[TBL] [Abstract][Full Text] [Related]
7. The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer.
Beresford MJ; Harris AL; Ah-See M; Daley F; Padhani AR; Makris A
Br J Cancer; 2006 Dec; 95(12):1683-8. PubMed ID: 17160082
[TBL] [Abstract][Full Text] [Related]
8. Functional imaging using diffuse optical spectroscopy of neoadjuvant chemotherapy response in women with locally advanced breast cancer.
Soliman H; Gunasekara A; Rycroft M; Zubovits J; Dent R; Spayne J; Yaffe MJ; Czarnota GJ
Clin Cancer Res; 2010 May; 16(9):2605-14. PubMed ID: 20406836
[TBL] [Abstract][Full Text] [Related]
9. Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.
Hylton NM; Blume JD; Bernreuter WK; Pisano ED; Rosen MA; Morris EA; Weatherall PT; Lehman CD; Newstead GM; Polin S; Marques HS; Esserman LJ; Schnall MD;
Radiology; 2012 Jun; 263(3):663-72. PubMed ID: 22623692
[TBL] [Abstract][Full Text] [Related]
10. Analysis of factors that influence the accuracy of magnetic resonance imaging for predicting response after neoadjuvant chemotherapy in locally advanced breast cancer.
Ko ES; Han BK; Kim RB; Ko EY; Shin JH; Hahn SY; Nam SJ; Lee JE; Lee SK; Im YH; Park YH
Ann Surg Oncol; 2013 Aug; 20(8):2562-8. PubMed ID: 23463090
[TBL] [Abstract][Full Text] [Related]
11. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of neoadjuvant chemotherapy for breast cancer in Turkish patients.
Duman BB; Afşar ÇU; Günaldi M; Sahin B; Kara IO; Erkisi M; Erçolak V
Asian Pac J Cancer Prev; 2012; 13(8):4119-23. PubMed ID: 23098527
[TBL] [Abstract][Full Text] [Related]
13. Effects of conventional neoadjuvant chemotherapy for breast cancer on tumor angiogenesis.
Luengo-Gil G; González-Billalabeitia E; Chaves-Benito A; García Martínez E; García Garre E; Vicente V; Ayala de la Peña F
Breast Cancer Res Treat; 2015 Jun; 151(3):577-87. PubMed ID: 25967462
[TBL] [Abstract][Full Text] [Related]
14. Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy.
Baek HM; Chen JH; Nie K; Yu HJ; Bahri S; Mehta RS; Nalcioglu O; Su MY
Radiology; 2009 Jun; 251(3):653-62. PubMed ID: 19276320
[TBL] [Abstract][Full Text] [Related]
15. Impact of Neoadjuvant Chemotherapy on Breast Cancer Subtype: Does Subtype Change and, if so, How? : IHC Profile and Neoadjuvant Chemotherapy.
De La Cruz LM; Harhay MO; Zhang P; Ugras S
Ann Surg Oncol; 2018 Nov; 25(12):3535-3540. PubMed ID: 29981025
[TBL] [Abstract][Full Text] [Related]
16. Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer.
Li L; Wang K; Sun X; Wang K; Sun Y; Zhang G; Shen B
Med Sci Monit; 2015 Feb; 21():376-82. PubMed ID: 25640082
[TBL] [Abstract][Full Text] [Related]
17. Optical mammography using diffuse optical spectroscopy for monitoring tumor response to neoadjuvant chemotherapy in women with locally advanced breast cancer.
Schaafsma BE; van de Giessen M; Charehbili A; Smit VT; Kroep JR; Lelieveldt BP; Liefers GJ; Chan A; Löwik CW; Dijkstra J; van de Velde CJ; Wasser MN; Vahrmeijer AL
Clin Cancer Res; 2015 Feb; 21(3):577-84. PubMed ID: 25473002
[TBL] [Abstract][Full Text] [Related]
18. Patient and tumor characteristics associated with breast cancer recurrence after complete pathological response to neoadjuvant chemotherapy.
Ju NR; Jeffe DB; Keune J; Aft R
Breast Cancer Res Treat; 2013 Jan; 137(1):195-201. PubMed ID: 23149464
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of Post-Neoadjuvant Chemotherapy Image-Guided Breast Biopsy to Predict Residual Cancer.
Tasoulis MK; Lee HB; Yang W; Pope R; Krishnamurthy S; Kim SY; Cho N; Teoh V; Rauch GM; Smith BD; Valero V; Mohammed K; Han W; MacNeill F; Kuerer HM
JAMA Surg; 2020 Dec; 155(12):e204103. PubMed ID: 33026457
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy may eradicate ductal carcinoma in situ (DCIS) but not the associated microcalcifications.
Goldberg H; Zandbank J; Kent V; Leonov-Polak M; Livoff A; Chernihovsky A; Guindy M; Evron E
Eur J Surg Oncol; 2017 Aug; 43(8):1415-1420. PubMed ID: 28526187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
